Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor

Published in: Journal of Pharmacology and Experimental Therapeutics

Volume 301, Issue 3, pp. 1020-1024

DOI: 10.1124/jpet.301.3.1020